Mortality Due to COVID-19 in the COVID-AGEBRU Study

CHU Brugmann University Hospital

Status: Completed

Conditions: Morbidity, Multiple; Covid19; Old Age; Debility

Study type: Observational

Funder types: Other

Identifiers

NCT04756479

COVID-19 AGE-BRUGMANN 2020/111

Details and patient eligibility

About

The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19

Full description

The COVID-19 disease has been shown to be associated to higher mortality risk and health adverse consequences. Despite of the fact that the SAR-COV2 virus has been shown that affects every populations, the negative impact is higher in older people, pointing this population as the most severely affected.

The COVID-Age Brugmann study aims to identify if comorbidity, geriatric syndromes, and health issues at admission are associated to mortality risk in older patients admitted to an acute care unit due to COVID-19

Enrollment: 160 patients

Sex: All

Ages: 70+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 70 and older
• Patients admitted to an acute care geriatric unit due to COVID-19
• Patients with COVID-19 by PCR, serology or CT scan suggestive of this disease

Exclusion criteria

• No other demographic or clinical exclusion criteria will be applied